CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

HSBC Adjusts Price Target on Biogen to $157 From $150

Neutral
AI Analysis

Summary

HSBC adjusted its price target on Biogen from $150 to $157. This is a routine analyst rating update with no material corporate catalyst.

Importance:1/10
Sentiment:
0.00
price_targetanalyst_coverage
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 11:33 AM

Read Original